Melissa Vázquez-Hernández

Melissa Vázquez-Hernández

Auto-generated profile, based on publicly available information

Melissa Vázquez-Hernández

Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2017 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
ARAlba Romero-Rodríguez
Alba Romero-Rodríguez
DRDiana Rocha-Mendoza
Diana Rocha-Mendoza
BRBeatriz Ruiz-Villafan
Beatriz Ruiz-Villafan
SGSilvia Guzmán-Trampe
Silvia Guzmán-Trampe
NCNidia Maldonado Carmona
Nidia Maldonado Carmona
Sergio SánchezSergio Sánchez
Sergio Sánchez

1 December 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
DMDieter Meier
Dieter Meier
MHMelissa Vázquez Hernández
Melissa Vázquez Hernández
LGLasse van Geelen
Lasse van Geelen
RMRini Muharini
Rini Muharini
PPPeter Proksch
Peter Proksch
RKRainer Kalscheuer
Rainer Kalscheuer

15 February 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Corina Diana CeapăCorina Diana Ceapă
Corina Diana Ceapă
MVMelissa Vázquez-Hernández
Melissa Vázquez-Hernández
SRStefany Daniela Rodríguez-Luna
Stefany Daniela Rodríguez-Luna
AVAngélica Patricia Cruz Vázquez
Angélica Patricia Cruz Vázquez
VSVerónica Jiménez Suárez
Verónica Jiménez Suárez
Sergio SánchezSergio Sánchez
Sergio Sánchez
Endophytic bacteria are wide-spread and associated with plant physiological benefits, yet their genomes and secondary metabolites remain largely unidentified. In this study, we explored the genome of the endophyte Streptomyces scabrisporus NF3 for discovery of potential novel molecules as well as genes and metabolites involved in host interactions. The complete genomes of seven Streptomyces and three other more distantly related bacteria were used to define the functional landscape of this unique microbe. The S. scabrisporus NF3 genome is larger than the average Streptomyces genome and not structured for an obligate endosymbiotic lifestyle; this and the fact that can grow in R2YE media implies that it could include a soil-living stage. The genome displays an enrichment of genes associated with amino acid production, protein secretion, secondary metabolite and antioxidants production and xenobiotic degradation, indicating that S. scabrisporus NF3 could contribute to the metabolic enrichment of soil microbial communities and of its hosts. Importantly, besides its metabolic advantages, the genome showed evidence for differential functional specificity and diversification of plant interaction molecules, including genes for the production of plant hormones, stress resistance molecules, chitinases, antibiotics and siderophores. Given the diversity of S. scabrisporus mechanisms for host upkeep, we propose that these strategies were necessary for its adaptation to plant hosts and to face changes in environmental conditions.

27 June 2019 in Inorganic Chemistry
Verified
Journal Article
Closed access
RMReece G. Miller
Reece G. Miller
MVMelissa Vázquez-Hernández
Melissa Vázquez-Hernández
PPPascal Prochnow
Pascal Prochnow
JBJulia Bandow
Julia Bandow
NMNils Metzler-Nolte
Nils Metzler-Nolte

6 March 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AMAnna-Maria Möller
Anna-Maria Möller
MVMelissa Vázquez-Hernández
Melissa Vázquez-Hernández
BKBlanka Kutscher
Blanka Kutscher
RBRaffael Brysch
Raffael Brysch
SBSimon Brückner
Simon Brückner
FNFranz Narberhaus
Franz Narberhaus
A promising yet clinically unexploited antibiotic target in difficult-to-treat Gram-negative bacteria is LpxC, the key enzyme in the biosynthesis of lipopolysaccharides, which are the major constituents of the outer membrane. Despite the development of dozens of chemically diverse LpxC inhibitor molecules, it is essentially unknown how bacteria counteract LpxC inhibition. Our study provides comprehensive insights into the response against five different LpxC inhibitors. All compounds bound to purified LpxC from Escherichia coli. Treatment of E. coli with these compounds changed the cell shape and stabilized LpxC suggesting that FtsH-mediated proteolysis of the inactivated enzyme is impaired. LpxC inhibition sensitized E. coli to vancomycin and rifampin, which poorly cross the outer membrane of intact cells. Four of the five compounds led to an accumulation of lyso-phosphatidylethanolamine, a cleavage product of phosphatidylethanolamine, generated by the phospholipase PldA. The combined results suggested an imbalance in lipopolysaccharides and phospholipid biosynthesis, which was corroborated by the global proteome response to treatment with the LpxC inhibitors. Apart from LpxC itself, FabA and FabB responsible for the biosynthesis of unsaturated fatty acids were consistently induced. Upregulated compound-specific proteins are involved in various functional categories, such as stress reactions, nucleotide, or amino acid metabolism and quorum sensing. Our work shows that antibiotics targeting the same enzyme do not necessarily elicit identical cellular responses. Moreover, we find that the response of E. coli to LpxC inhibition is distinct from the previously reported response in Pseudomonas aeruginosa.

1 October 2019 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
NCNidia Maldonado Carmona
Nidia Maldonado Carmona
MVMelissa Vázquez-Hernández
Melissa Vázquez-Hernández
OCOsiris Jair Patiño Chávez
Osiris Jair Patiño Chávez
SRStefany Daniela Rodríguez-Luna
Stefany Daniela Rodríguez-Luna
OROmar Jiménez Rodríguez
Omar Jiménez Rodríguez
Corina Diana CeapăCorina Diana Ceapă
Corina Diana Ceapă